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Background
Emerging pathogens pose a continuous threat to mankind, as exemplified by the Ebola 
virus epidemic in West Africa in 2014 [1], Zika virus pandemic in 2015 [2], and the 
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ongoing Coronavirus disease 2019 (COVID-19) pandemic. These viruses are zoonotic, 
i.e. have crossed species barriers from animals to humans, alike the majority of emerg-
ing human pathogens [3, 4]. The likelihood of this host switching is enhanced by several 
factors, e.g. global movement of people and animals, environmental changes, increased 
proximity of humans, wildlife and livestock, and population expansion into new envi-
ronments [5].
The mutation and evolution rate of RNA viruses is considerably higher than their 
hosts, which is advantageous for viral adaptation. Mutations in the viral genome are 
most of the time silent or, if affecting phenotype, related to attenuation, although muta-
tions can also lead to more pathogenic strains. A new virus variant may have one or 
more mutations that separate it from the wild-type virus already circulating among the 
general population.
Coronaviruses (family Coronaviridae) are enveloped single-stranded RNA viruses, 
which cause respiratory, enteric, hepatic, and neurological diseases of a broad spectrum 
of severity among different animals and humans. Severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), a novel evolutionary divergent virus responsible for the 
present pandemic, has devastated societies and economies globally. The SARS-CoV-2 
pandemic has already infected more than 100 million people in 221 countries, causing 
over 2.2 million global deaths as of 3rd February 2021 [6]. In autumn 2020, a new variant 
of SARS-CoV-2 known as 20B/501Y.V1 (B.1.1.7) was detected in south-eastern England, 
Wales, and Scotland [7]. This variant has since spread globally to more than 80 coun-
tries. The variant has undergone 23 mutations with 13-nonsynonymous mutations, four 
amino acid deletions, and six synonymous mutations making the virus more transmis-
sible [8]. Another variant 20C/501Y.V2 (B.1.351) was detected in South Africa which was 
genetically distant from the UK 20B/501Y.V1 variant [9]. This South African variant with 
its two mutations in the receptor-binding motif that mainly forms the interface with the 
human ACE2 receptor has also been widely spreading to circulate globally. It has been 
noticed that some existing vaccines against SARS-CoV-2 are less effective against the 
20C/501Y.V2 variant [10–12]. A third variant being closely monitored is P.1 detected 
first in Brazil [13]. Interestingly, all these three variants have a mutation in the receptor 
binding domain (RBD) of the spike protein at position 501, where the amino acid aspara-
gine (N) has been replaced with tyrosine (Y) enabling specific PCR to detect the N501Y 
mutation [14].
Sequencing and computing consensus sequences or genomes from RNA viruses pre-
sent certain challenges. The mutation and evolution rate of RNA viruses is considerably 
higher than their hosts, which is advantageous for viral adaptation. Mutations in the 
viral genome are most of the time silent or, if affecting phenotype, related to attenua-
tion, although mutations can also lead to more pathogenic strains. A new virus variant 
may have one or more mutations that separate it from the wild-type virus already cir-
culating among the general population. To detect these minor changes in viral genomes 
requires bioinformatic tools with high accuracy and sensitivity, which tend to come 
at the expense of computing speed. Currently, the most common sequencing method 
employed with SARS-CoV-2 is a combination of PCR-based amplification followed 
by Illumina sequencing. The resulting reads are then pre-processed and quality-con-
trolled for either a de novo or a reference-based assembly. To identify to what variant 
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a sequenced SARS-CoV-2 belongs to, it is usually analyzed and classified with pangolin 
[15] or Nextclade, which is a part of Nextstrain [16]. Each tool utilizes different nomen-
clature for classification [17, 18]. To date, most of the resulting sequences are submitted 
to the GISAID database [19, 20] (contains over 1 million sequences as of May 1, 2020), 
which has another classification system for the virus.
As more transmissible coronavirus variants are circulating worldwide, the role of 
researchers and technology specialists in controlling the pandemic has received more 
emphasis. The surveillance of virus variants by sequencing the SARS-CoV-2 genomes 
would provide a fast way to monitor variants and their spread, however, there are only 
few publicly available methods for quick reference-based consensus assembly and line-
age assignment for SARS-CoV-2 samples. For this purpose, we have developed a simple 
pipeline, called HAVoC (Helsinki university Analyzer for Variants of Concern), for quick 
reference-based consensus assembly from short reads sequenced with Illumina and lin-
eage assignment for SARS-CoV-2 samples. This will provide the end user a quick and 
accessible method of variant identification and monitoring. The pipeline was developed 
to be run on Unix/Linux operating systems, and thus can also be used in remote servers, 
e.g. CSC—IT Center for Science, Finland.
Implementation
HAVoC consists of a single shell script, which performs reference-based consensus 
assemblies to query SARS-CoV-2 FASTQ sequence libraries and assigns lineages to 
them individually in succession. It does this using several bioinformatic tools publicly 
available in Bioconda on Unix/Linux platforms. For HAVoC to be utilized, the user is 
required to install these dependencies. This can be done for example via Biocanda with 
the following command:
conda install fastp trimmomatic bowtie2 bwa sambamba samtools bedtools lofreq 
bcftools pangolin
The script can be started by typing the following line into your command line terminal:
sh HAVoC.sh [FASTQ directory]
The computing of consensus sequences starts with the tool detecting FASTQ files gen-
erated via paired end sequencing in a given input directory and checking that each query 
FASTQ file has its corresponding counterpart, i.e. mates file. The names of the files are 
modified to be more concise, e.g. Query-Seq:1_X123_Y000_R1_000.fastq.gz to Query-
Seq:1_R1.fastq.gz. The pipeline accepts FASTQ files both in gzipped and uncompressed 
format.
For the analyses, the user can choose one of two bioinformatic tools to utilize in each 
phase of the assembly. This can be done by typing the tool wanted (tools_prepro, tools_
aligner and tools_sam) within the options section in the beginning of the script file. For 
example, if the user wants to deploy Trimmomatic to pre-process FASTQ files, the fol-
lowing line can be changed as follows:
From
tools_prepro="fastp"
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To
tools_prepro="trimmomatic"
Other options include the number of threads, minimum coverage below which a 
region is masked (min_coverage), and whether to run pangolin to assign lineages to the 
consensus genome (run_pangolin). An additional option allows HAVoC to be run in the 
CSC servers (run_in_csc).
The pre-alignment quality control, e.g. removing and trimming low quality reads and 
bases, removing adapter sequences, can be done with either fastp [21] or Trimmomatic 
[22]. The former is used by default due to its faster processing speed. Also unlike Trim-
momatic, fastp does not require a separate file with adapters (NexteraPE-PE.fa or other 
provided by the user) making it more usable for different sequencing protocols. In addi-
tion to increasing the quality of the reads, this step reduces the time of the following 
alignment process in which the reads are then aligned to a reference genome of SARS-
CoV-2 isolate Wuhan-Hu-1 (Genbank accession code: NC_045512.2) provided in the ref.
fa file with BWA-MEM [23] or Bowtie 2 [24]. The end-user may also provide their own 
reference genome in fasta format by copying it directly to the ref.fa file. BWA-MEM is 
chosen by default due to it being faster compared to other contemporary tools utilizing 
different alignment techniques [25]. For higher coverage contigs, the user may want to 
use Bowtie 2 instead. The resulting SAM and BAM files are processed (includes sort-
ing, filling in mate coordinates, marking duplicate alignments, and indexing reads) with 
Sambamba [26] or Samtools [27] and the low coverage regions are masked with BED-
tools [28]. After masking a variant call is done with LoFreq [29] before computing the 
consensus sequence via BCFtools of Samtools [27]. Finally, the consensus sequence is 
analyzed with pangolin [15] to assign a lineage. The whole process is depicted in Fig. 1.
Usage example
We are going to demonstrate a common use case for HAVoC with FASTQ files contain-
ing reads for SARS-CoV-2 sequences, provided by the Viral zoonoses research unit at 
University of Helsinki, Finland. The reads were produced via Illumina sequencing. The 
test files within the Example_FASTQs folder contain paired-end FASTQ files for the UK 
variant (UK-variant-1) and the South African variant (S-Africa-variant-1). To analyse 
these example files, the aforementioned command needs to be deployed as follows:
sh HAVoC.sh Example_FASTQs
Results
The FASTQ files are processed and analyzed with the default options utilizing faster 
bioinformatic tools (fastp, BWA-MEM and Sambamba) in ca. 2–5 min, depending on 
the performance of the platform (local or server) and the size of the input FASTQ files. 
After HaVoc has finished the analyses, each FASTQ file is moved to their respective 
result folders within the FASTQ directory. Each result folder contains a FASTA file for 
the consensus sequence (e.g. UK-variant-1_consensus.fa) and a CSV file with the lineage 
information produced by pangolin (e.g. UK-variant-1_pangolin_lineage.csv). In addition 
to these main result files, each directory contains the original FASTQ files, BAM files 
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(original, indexed and sorted), variant call files (VCF) with mutation data, BED file used 
for masking regions, and fastp report files with the results of FASTQ processing. The 










Fig. 1 Flowchart describing processes and steps performed by HAVoC pipeline. The pipeline constructs 
consensus sequences from all FASTQ files in an input directory and then compares the resulting sequences 
to other established SARS-CoV-2 genomes to assign them the most likely lineages. The pipeline requires 
a FASTA file of adapter sequences for FASTQ pre-processing and a reference genome of SARS-CoV-2 in a 
separate FASTA file. The adapter file is not required when running the pipeline with fastp option. Input files 
are highlighted in green and the outputs in red

























Each of the example UK variants should have been categorized as B.1.1.7 and 
the South African variants as B.1.351 (with pangoLEARN release 2021-02-06). It is 
important to note however, that as more sequences are uploaded and the pangolin 
lineage nomenclature updated, the assigned lineages may differ from the expected 
ones described in this paper.
Regions with low coverages (with default setting under 30) are marked with the let-
ter N during masking and represent gaps in the final consensus sequences.
HAVoC is comparable to alternative combinations of tools, e.g. Jovian and pangolin, 
in both speed and accuracy. These tools however operate separately, and as of pub-
lishing, there are no single public tools that can both perform a reference-based con-
sensus assembly and a lineage identification in an easily accessible manner.
Conclusions
Early detection and understanding of the potential impact of emerging variants of SARS-
CoV-2 is of primary importance and can assist in more efficient surveillance and control 
of the disease. The likelihood of emergence of novel SARS-CoV-2 variants of concern 
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is increased and accelerated by the high mutation rates typical in RNA viruses and the 
growing number of transmissions and infections both locally and globally.
With the rising number of variants detected worldwide and with many of them asso-
ciated with increased transmissibility and lower vaccine efficacy, there is an emerging 
need for fast, efficient and reliable pipelines to help detect, identify and trace SARS-
CoV-2 lineages. These pipelines should in addition be accessible to researchers who may 
not be familiar with utilizing complex bioinformatic tools or scripting pipelines.
Due to these challenges, we have developed HAVoC, a simple, reliable and user-friendly 
pipeline, which can be simply downloaded from our repository and run without being 
installed. The pipeline performs reference-based assemblies and lineage assignment 
from SARS-CoV-2 samples sequenced with Illumina utilizing a combination of multiple 
well-established third-party bioinformatic tools in current use. All its dependencies can 
be installed via existing package managers, of which we recommend Bioconda. HAVoC 
is currently being developed and updated in addition to being utilized for detecting and 
tracing SARS-CoV-2 variants of concern, mainly B.1.1.7, B1.351 and P.1, in Finland.
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